North Dakota Statutes
§ 23-23.1-02 — Disciplinary action for administering or prescribing laetrile subject to finding of harmfulness
North Dakota § 23-23.1-02
This text of North Dakota § 23-23.1-02 (Disciplinary action for administering or prescribing laetrile subject to finding of harmfulness) is published on Counsel Stack Legal Research, covering North Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
N.D. Cent. Code § 23-23.1-02 (2026).
Text
finding of harmfulness.
No physician may be subject to disciplinary action by the North Dakota board of medicine
for prescribing or administering amygdalin to a patient under the physician's care who has
requested the substance unless the board, in a hearing conducted pursuant to chapter 28-32,
has made a formal finding that the substance is harmful.
Free access — add to your briefcase to read the full text and ask questions with AI
Nearby Sections
15
§ 23-01-01
Health division - Officers§ 23-01-01.1
Department of health and human services to replace state department of health and consolidated laboratories§ 23-01-02.1
Hospital utilization committees - Internal quality assurance review committees - Reports - Immunity§ 23-01-03
Powers and duties of the health council§ 23-01-03.2
Duties of the health council§ 23-01-04
Effect of rules and regulations§ 23-01-04.1
Rulemaking authority and procedure§ 23-01-04.2
Legislative intent - Health vaccination chargesCite This Page — Counsel Stack
Bluebook (online)
North Dakota § 23-23.1-02, Counsel Stack Legal Research, https://law.counselstack.com/statute/nd/23-23.1-02.